These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18498703)

  • 1. Transdermal delivery enhancement of haloperidol from gel formulations by 1,8-cineole.
    Elgorashi AS; Heard CM; Niazy EM; Noureldin OH; Pugh WJ
    J Pharm Pharmacol; 2008 Jun; 60(6):689-92. PubMed ID: 18498703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of d-limonene, alpha-pinene and cineole on in vitro transdermal human skin penetration of chlorpromazine and haloperidol.
    Almirall M; Montaña J; Escribano E; Obach R; Berrozpe JD
    Arzneimittelforschung; 1996 Jul; 46(7):676-80. PubMed ID: 8842336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole.
    Ahad A; Aqil M; Ali A
    Int J Biol Macromol; 2014 Mar; 64():144-9. PubMed ID: 24296403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
    Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
    Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation variables in transdermal drug delivery system containing zolmitriptan.
    Subedi RK; Ryoo JP; Moon C; Choi HK
    Int J Pharm; 2011 Oct; 419(1-2):209-14. PubMed ID: 21843607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMGA gels for the skin permeation of haloperidol.
    Kang L; Liu XY; Sawant PD; Ho PC; Chan YW; Chan SY
    J Control Release; 2005 Aug; 106(1-2):88-98. PubMed ID: 15975680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface tension and wettability in transdermal delivery: a study on the in-vitro permeation of haloperidol with cyclodextrin across human epidermis.
    Azarbayjani AF; Lin H; Yap CW; Chan YW; Chan SY
    J Pharm Pharmacol; 2010 Jun; 62(6):770-8. PubMed ID: 20636865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and characterization of submicron formulation for a poorly soluble drug: the effect of Vitamin E TPGS and other solubilizers on skin permeability enhancement.
    Ghosh I; Michniak-Kohn B
    Int J Pharm; 2012 Sep; 434(1-2):90-8. PubMed ID: 22633930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxypropylmethylcellulose films for prolonged delivery of the antipsychotic drug chlorpromazine.
    Luppi B; Bigucci F; Baldini M; Abruzzo A; Cerchiara T; Corace G; Zecchi V
    J Pharm Pharmacol; 2010 Mar; 62(3):305-9. PubMed ID: 20487212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the loratadine gel for enhanced transdermal delivery.
    Song JH; Shin SC
    Drug Dev Ind Pharm; 2009 Aug; 35(8):897-903. PubMed ID: 19241201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the ambroxol gels for enhanced transdermal delivery.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2008 Mar; 34(3):330-5. PubMed ID: 18363149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action.
    Narishetty ST; Panchagnula R
    J Control Release; 2004 Mar; 95(3):367-79. PubMed ID: 15023449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, in vitro, and in vivo evaluation of matrix-type transdermal patches containing olanzapine.
    Aggarwal G; Dhawan S; Harikumar SL
    Pharm Dev Technol; 2013; 18(4):916-25. PubMed ID: 21913873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.
    Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA
    Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy.
    Mura S; Manconi M; Fadda AM; Sala MC; Perricci J; Pini E; Sinico C
    Pharm Dev Technol; 2013; 18(6):1339-45. PubMed ID: 22563642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl.
    Karakatsani M; Dedhiya M; Plakogiannis FM
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1195-206. PubMed ID: 20545504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size.
    Fahmy AM; El-Setouhy DA; Habib BA; Tayel SA
    AAPS PharmSciTech; 2019 Jan; 20(3):95. PubMed ID: 30694404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nortriptyline hydrochloride skin absorption: development of a transdermal patch.
    Melero A; Garrigues TM; Almudever P; Villodre AM; Lehr CM; Schäfer U
    Eur J Pharm Biopharm; 2008 Jun; 69(2):588-96. PubMed ID: 18191555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.